Merck & Co., Inc. (JOBS) Takeover Threatens Schering-Plough Corporation’s (JOBS) Ties with Johnson & Johnson

March 11, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Johnson & Johnson, the US pharmaceuticals group, has a month to decide whether to try to claim back full rights over two pivotal medicines as a result of Merck’s $41bn (£29.8bn) planned takeover of Schering-Plough.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions

Johnson & Johnson Family of Companies Merck & Co.